Supriya Lifescience Limited — Others, 07-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Supriya Lifescience has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The company has received a certificate from MUFG Intime India Private Limited, confirming the validation of securities for dematerialisation in the same period. This update signifies robust compliance with operational protocols, thereby ensuring smooth transactions and maintaining investor trust. For investors, this demonstrates a structured approach to governance, which could foster a positive outlook, reflecting the company's commitment to transparency and operational effectiveness.